Takanori Matsui

12PUBLICATIONS
30CO-AUTHORS
Econometric and statistical methodsPredictive and prognostic markersToxicology (incl. clinical toxicology)Chemical engineering designEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 05, 2026
Effects of esaxerenone add-on therapy versus angiotensin II receptor blocker dose escalation on albuminuria and blood pressure in hypertensive patients with type 2 diabetes: An exploratory randomized study.

|Aug 11, 2025
Sulforaphane inhibits cardiac fibrosis induced by advanced glycation end product-receptor axis through its anti-oxidative property.

Takanori Matsui, Tatsuya Sakaguchi, Yuichiro Higashimoto

|Apr 17, 2025
Apixaban Inhibits Progression of Experimental Diabetic Nephropathy by Blocking Advanced Glycation End Product-Receptor Axis.

Takanori Matsui, Ami Sotokawauchi, Yuri Nishino

|Dec 05, 2024
Involvement of Mineralocorticoid Receptor Activation by High Mobility Group Box 1 and Receptor for Advanced Glycation End Products in the Development of Acute Kidney Injury.

Tomoyuki Otsuka, Seiji Ueda, Sho-Ichi Yamagishi

|Sep 14, 2024
Glucose-Dependent Insulinotropic Polypeptide Inhibits AGE-Induced NADPH Oxidase-Derived Oxidative Stress Generation and Foam Cell Formation in Macrophages Partly via AMPK Activation.

Michishige Terasaki, Hironori Yashima, Yusaku Mori

|Jun 19, 2024
DNA Aptamer Raised against Advanced Glycation End Products Improves Sperm Concentration, Motility, and Viability by Suppressing Receptors for Advanced Glycation End Product-Induced Oxidative Stress and Inflammation in the Testes of Diabetic Mice.

Yusaku Mori, Michishige Terasaki, Naoya Osaka

Pageof 2

Frequent Collaborators

8 joint publications

Sho-Ichi Yamagishi

5 joint publications

Yusaku Mori

5 joint publications

Yuichiro Higashimoto

4 joint publications

Ami Sotokawauchi